Sign In
Buy RXRX
$3.52
+0.180 (+5.39%)
At Close: Jun 26, 2026
Cathie Wood Just Made a Big Bet on Recursion Pharmaceuticals Stock. Will It Pay Off?
08:00am, Tuesday, 21'st Nov 2023
Cathie Wood just massively increased her holdings of Recursion Pharmaceuticals. But the company will probably take a few more years to demonstrate its value.
AI Alert: 3 Healthcare Stocks That Are Investing in Artificial Intelligence
07:11pm, Thursday, 09'th Nov 2023
We're still in the initial stages of a massively disruptive artificial intelligence ( AI ) boom. Big Tech is investing billions of dollars into it.
Recursion to Participate in Upcoming Investor Conference
08:05am, Thursday, 02'nd Nov 2023
SALT LAKE CITY, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation
3 Extra-Speculative Stocks That Could Make You Very, Very Rich
11:01pm, Thursday, 26'th Oct 2023
Speculative stocks are a risky proposition in today's market. With even the Standard and Practices (S&P) 500's stablest giants dropping, small-cap risky stocks don't stand a chance.
2 Risky Stocks With Massive Potential
09:53am, Tuesday, 17'th Oct 2023
Recursion Pharmaceuticals is looking to introduce a paradigm shift in the way biotechs develop drugs. Madrigal Pharmaceuticals developed a therapy for a disease that has eluded many of its larger peer
1 Artificial Intelligence Stock to Buy Hand Over Fist in October and 1 to Avoid
06:00am, Friday, 13'th Oct 2023
The AI in healthcare market may be worth more than $190 billion by the end of this decade, making it a great place to look for investing opportunities. It's important to consider the whole picture whe
Is Recursion Pharmaceuticals Stock a Buy Now?
10:07am, Wednesday, 11'th Oct 2023
Recursion Pharmaceuticals is using a novel and promising approach to drug discovery. Its strategy has produced some candidates, but none yet seems close to approval.
2 Cathie Wood Stocks I'm Bullish On
08:45am, Thursday, 05'th Oct 2023
Investor Cathie Wood has an eye for powerful trends in high-tech areas of the market. She has been hitting the buy button lately on Beam Therapeutics and Recursion Pharmaceuticals.
2 AI Stocks That Aren't Worth the Hype
09:15am, Wednesday, 04'th Oct 2023
Shares of Recursion Pharmaceuticals and C3.ai spiked this year due to AI. Both business are unprofitable, however, and that's not likely to change soon.
2 Cathie Wood Stocks That Could Deliver Exponential Returns
10:45am, Monday, 02'nd Oct 2023
Cathie Wood is a thematic investor focused on disruptive new technologies. Recursion Pharmaceuticals could radically transform the drug discovery/development process.
Is Recursion Pharmaceuticals Stock a Buy?
09:15am, Saturday, 30'th Sep 2023
It has multiple programs in its pipeline, which focuses on rare diseases and cancer. Its use of artificial intelligence made the stock a hot buy earlier this year.
Immunomics Stocks: 3 Ways to Play This Massive AI-Biotech Megatrend
05:05pm, Friday, 22'nd Sep 2023
Biotech has long seemed to move slower than its fellow tech fields due to the complexity of biological systems and the difficulty of drug regulations. However, that precedent is set to change thanks t
3 Stocks Cathie Wood Is Buying That Should Be on Your List, Too
05:50am, Friday, 22'nd Sep 2023
Beam Therapeutics is pioneering a promising type of gene editing. Recursion Pharmaceuticals is harnessing AI to improve drug discovery.
Better Growth Stock: Recursion Pharmaceuticals vs. CRISPR Therapeutics
10:07am, Friday, 15'th Sep 2023
The timing of upcoming catalysts is a key consideration when comparing biotechs. Recursion Pharmaceuticals may make more revenue soon, but not from its pipeline.
2 Growth Stocks That Could Rocket 88% to 99% Higher According to Wall Street
05:14am, Tuesday, 12'th Sep 2023
The consensus price target for Recursion Pharmaceuticals suggests the stock can soar 88% from recent prices. The average analyst estimates for bluebird bio stock imply a gain of 99% over the next 12 m
